Study paves way for revolutionizing the management of muscle disorders

The type 1 ryanodine receptor (RyR1) is an important calcium release channel in skeletal muscles essential for muscle contraction.

Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says

With the newly dubbed “cardiovascular-kidney-metabolic (CKM) syndrome,” the American Heart Association (AHA) expands concepts of cardiovascular risk, prevention, and management in a framework that touches

October 10, 2023

Function Health and GRAIL Collaborate to Make Multi-Cancer Early Detection Test More Accessible

What You Should Know: – Function Health, a revolutionary health management platform empowering people to live 100 healthy years, announces a collaboration with GRAIL, Inc., a

December 4, 2024

Gilead wins U.S. approval for drug to treat autoimmune liver disease

The Food and Drug Administration on Wednesday approved a new treatment for primary biliary cholangitis, an autoimmune liver disease mainly affecting women that causes decreased

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.